These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27502717)

  • 1. Tumor-related leukocytosis is associated with poor radiation response and clinical outcome in uterine cervical cancer patients.
    Cho Y; Kim KH; Yoon HI; Kim GE; Kim YB
    Ann Oncol; 2016 Nov; 27(11):2067-2074. PubMed ID: 27502717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC; Wang L; Lin JC; Jan JS
    J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine cervical cancer displaying tumor-related leukocytosis: a distinct clinical entity with radioresistant feature.
    Mabuchi S; Matsumoto Y; Kawano M; Minami K; Seo Y; Sasano T; Takahashi R; Kuroda H; Hisamatsu T; Kakigano A; Hayashi M; Sawada K; Hamasaki T; Morii E; Kurachi H; Matsuura N; Kimura T
    J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24948742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Radiation Field Failure After Definitive Chemoradiation in Patients With Locally Advanced Cervical Cancer.
    Bae HS; Kim YJ; Lim MC; Seo SS; Park SY; Kang S; Kim SH; Kim JY
    Int J Gynecol Cancer; 2016 May; 26(4):737-42. PubMed ID: 26937749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.
    Werner-Wasik M; Schmid CH; Bornstein L; Ball HG; Smith DM; Madoc-Jones H
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1309-17. PubMed ID: 7635770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy is a safe and effective salvage treatment for recurrent cervical cancer.
    Kim HJ; Chang JS; Koom WS; Lee KC; Kim GE; Kim YB
    Gynecol Oncol; 2018 Nov; 151(2):208-214. PubMed ID: 30195468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group study.
    Rose PG; Ali S; Whitney CW; Lanciano R; Stehman FB
    Gynecol Oncol; 2011 Jun; 121(3):542-5. PubMed ID: 21420157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective study.
    Atahan IL; Onal C; Ozyar E; Yiliz F; Selek U; Kose F
    Int J Gynecol Cancer; 2007; 17(4):833-42. PubMed ID: 17367320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
    Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Highly Metastatic Nature of Uterine Cervical/Endometrial Cancer Displaying Tumor-Related Leukocytosis: Clinical and Preclinical Investigations.
    Sasano T; Mabuchi S; Kozasa K; Kuroda H; Kawano M; Takahashi R; Komura N; Yokoi E; Matsumoto Y; Hashimoto K; Sawada K; Morii E; Kimura T
    Clin Cancer Res; 2018 Aug; 24(16):4018-4029. PubMed ID: 29752277
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment outcomes of extended-field radiation therapy and the effect of concurrent chemotherapy on uterine cervical cancer with para-aortic lymph node metastasis.
    Yoon HI; Cha J; Keum KC; Lee HY; Nam EJ; Kim SW; Kim S; Kim YT; Kim GE; Kim YB
    Radiat Oncol; 2015 Jan; 10():18. PubMed ID: 25582425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation therapy for stage IVA cervical cancer.
    Murakami N; Kasamatsu T; Morota M; Sumi M; Inaba K; Ito Y; Itami J
    Anticancer Res; 2013 Nov; 33(11):4989-94. PubMed ID: 24222140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
    Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
    Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
    Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
    Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-related leukocytosis predictive of recurrence and survival in patients with oral cavity squamous cell carcinoma.
    Roh JL; Lee H; Choi SH; Nam SY; Kim SY
    Oral Dis; 2019 Sep; 25(6):1511-1518. PubMed ID: 31165559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definitive Chemoradiotherapy in Elderly Cervical Cancer Patients: A Multiinstitutional Analysis.
    Guler OC; Sari SY; Birgi SD; Gultekin M; Yildiz F; Onal C
    Int J Gynecol Cancer; 2017 Sep; 27(7):1446-1454. PubMed ID: 28604459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
    Morris M; Eifel PJ; Lu J; Grigsby PW; Levenback C; Stevens RE; Rotman M; Gershenson DM; Mutch DG
    N Engl J Med; 1999 Apr; 340(15):1137-43. PubMed ID: 10202164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for pelvic and distant recurrence in locally advanced cervical cancer.
    Queiroz ACM; Fabri V; Mantoan H; Sanches SM; Guimarães APG; Ribeiro ARG; da Nogueira Silveira Lima JP; Chen MJ; Baiocchi G; da Costa AABA
    Eur J Obstet Gynecol Reprod Biol; 2019 Apr; 235():6-12. PubMed ID: 30771718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and survival in patients with metastatic or recurrent carcinoma of the uterine cervix.
    Eralp Y; Saip P; Sakar B; Kucucuk S; Aydiner A; Dincer M; Aslay I; Topuz E
    Int J Gynecol Cancer; 2003; 13(4):497-504. PubMed ID: 12911727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended field radiotherapy with or without chemotherapy in patients with cervical cancer and positive para-aortic lymph nodes: a single institution retrospective review.
    Ng BH; Rozita A; Adlinda A; Lee WC; Wan Zamaniah W
    Asian Pac J Cancer Prev; 2015; 16(9):3827-33. PubMed ID: 25987044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.